KoreaMed Synapse

213

Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023

Hsu-Heng Yen, Jia-Feng Wu, Horng-Yuan Wang, Ting-An Chang, Chung-Hsin Chang, Chen-Wang Chang, Te-Hsin Chao, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tzu-Chi Hsu, Tien-Yu Huang, Tsung-I Hung, Puo-Hsien Le, Chun-Che Lin, Chun-Chi Lin, Ching-Pin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chia-Tung Shun, Tzung-Jiun Tsai, Cheng-Yi Wang, Meng-Tzu Weng, Jau-Min Wong, Deng-Chyang Wu, Shu-Chen Wei

KMSID: 1516087938 Intest Res. 2024;22(3):213-249. Published online 2024 July 29 DOI: http://dx.doi.org/10.5217/ir.2023.00050

250

Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023

Jia-Feng Wu, Hsu-Heng Yen, Horng-Yuan Wang, Ting-An Chang, Chung-Hsin Chang, Chen-Wang Chang, Te-Hsin Chao, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tzu-Chi Hsu, Tien-Yu Huang, Tsung-I Hung, Puo-Hsien Le, Chun-Che Lin, Chun-Chi Lin, Ching-Pin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chia-Tung Shun, Tzung-Jiun Tsai, Cheng-Yi Wang, Meng-Tzu Weng, Jau-Min Wong, Deng-Chyang Wu, Shu-Chen Wei

KMSID: 1516087948 Intest Res. 2024;22(3):250-285. Published online 2024 July 29 DOI: http://dx.doi.org/10.5217/ir.2024.00060

286

Diagnostic strategy of irritable bowel syndrome: a low- and middle-income country perspective

Amal Arifi Hidayat, Langgeng Agung Waskito, Titong Sugihartono, Hafeza Aftab, Yudith Annisa Ayu Rezkitha, Ratha-korn Vilaichone, Muhammad Miftahussurur

KMSID: 1516087946 Intest Res. 2024;22(3):286-296. Published online 2024 March 26 DOI: http://dx.doi.org/10.5217/ir.2023.00199

297

Intestinal ultrasound for intestinal Behçet disease reflects endoscopic activity and histopathological findings

Katsuki Yaguchi, Reiko Kunisaki, Sho Sato, Kaori Hirai, Misato Izumi, Yoshimi Fukuno, Mami Tanaka, Mai Okazaki, Rongrong Wu, Yurika Nishikawa, Yusuke Matsune, Shunsuke Shibui, Yoshinori Nakamori, Masafumi Nishio, Mao Matsubayashi, Tsuyoshi Ogashiwa, Ayako Fujii, Kenichiro Toritani, Hideaki Kimura, Eita Kumagai, Yukiko Sasahara, Yoshiaki Inayama, Satoshi Fujii, Toshiaki Ebina, Kazushi Numata, Shin Maeda

KMSID: 1516087943 Intest Res. 2024;22(3):297-309. Published online 2024 July 16 DOI: http://dx.doi.org/10.5217/ir.2023.00129

310

Adequacy of sigmoidoscopy as compared to colonoscopy for assessment of disease activity in patients of ulcerative colitis: a prospective study

Sameet Tariq Patel, Anuraag Jena, Sanjay Chandnani, Shubham Jain, Pankaj Nawghare, Saurabh Bansal, Harsh Gandhi, Rishikesh Malokar, Jay Chudasama, Prasanta Debnath, Seemily Kahmei, Rima Kamat, Sangeeta Kini, Qais Q Contractor, Pravin M Rathi

KMSID: 1516087944 Intest Res. 2024;22(3):310-318. Published online 2024 May 16 DOI: http://dx.doi.org/10.5217/ir.2023.00174

319

Association between oral corticosteroid starting dose and the incidence of pneumonia in Japanese patients with ulcerative colitis: a nation-wide claims database study

Katsuyoshi Matsuoka, Tomoyuki Inoue, Hiroaki Tsuchiya, Katsumasa Nagano, Toshiyuki Iwahori

KMSID: 1516087939 Intest Res. 2024;22(3):319-335. Published online 2024 February 6 DOI: http://dx.doi.org/10.5217/ir.2023.00071

336

Effects of COVID-19 vaccines on patient-reported outcomes in patients with inflammatory bowel disease: a multicenter survey study in Korea

Jung Hyun Ji, Seung Hwan Shin, Yong Eun Park, Jihye Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim, Sang-Bum Kang, Sang Hyoung Park, Soo Jung Park

KMSID: 1516087940 Intest Res. 2024;22(3):336-350. Published online 2024 March 26 DOI: http://dx.doi.org/10.5217/ir.2023.00077

351

Ustekinumab for anti-tumor necrosis factor refractory pediatric ulcerative colitis: a promising approach towards endoscopic healing

Rahiya Rehman, Muhammad Safwan Riaz, Dyadin Esharif, Phinnara Has, Michael Herzlinger, Jason Shapiro, Shova Subedi

KMSID: 1516087941 Intest Res. 2024;22(3):351-356. Published online 2024 February 6 DOI: http://dx.doi.org/10.5217/ir.2023.00091

357

Changes in the clinical course and prognosis of ulcerative colitis in Chinese populations: a retrospective cohort study

Xinyu Liu, Qingfan Yang, Na Diao, Jian Tang, Zicheng Huang, Xiang Gao, Kang Chao

KMSID: 1516087942 Intest Res. 2024;22(3):357-368. Published online 2024 May 7 DOI: http://dx.doi.org/10.5217/ir.2023.00106

369

Long-term efficacy and safety of tofacitinib in patients with ulcerative colitis: 3-year results from a real-world study

Hiromichi Shimizu, Yuko Aonuma, Shuji Hibiya, Ami Kawamoto, Kento Takenaka, Toshimitsu Fujii, Eiko Saito, Masakazu Nagahori, Kazuo Ohtsuka, Ryuichi Okamoto

KMSID: 1516087945 Intest Res. 2024;22(3):369-377. Published online 2024 July 16 DOI: http://dx.doi.org/10.5217/ir.2023.00194

378

Live-attenuated vaccination in patients with inflammatory bowel disease while continuing or after elective switch to vedolizumab

Hisashi Shiga, Hiroshi Nagai, Yusuke Shimoyama, Takeo Naito, Rintaro Moroi, Yoichi Kakuta, Yoshitaka Kinouchi, Atsushi Masamune

KMSID: 1516087947 Intest Res. 2024;22(3):378-386. Published online 2024 March 26 DOI: http://dx.doi.org/10.5217/ir.2023.00203

387

Halitosis: an underestimated but important extraintestinal manifestation in inflammatory bowel disease

Xiao Xian Qian

KMSID: 1516087949 Intest Res. 2024;22(3):387-388. Published online 2024 May 7 DOI: http://dx.doi.org/10.5217/ir.2024.00016